TGF-β Receptor Controls B Cell Responsiveness and Induction of IgA In Vivo  by Cazac, Balthazar B & Roes, Jürgen
Immunity, Vol. 13, 443–451, October, 2000, Copyright ª 2000 by Cell Press
TGF-b Receptor Controls B Cell
Responsiveness and Induction of IgA In Vivo
Given the complexity of the TGF-b12/2 phenotype, how-
ever, it has been difficult to establish the effects of TGF-b
on individual leukocyte subsets in vivo.
Balthazar B. Cazac and Ju¨rgen Roes*
Department of Medicine
The Windeyer Institute of Medical Sciences
University College London TGF-b cytokines are implicated in the control of many
biological processes, including embryonic develop-46 Cleveland Street
London W1P 6DB ment, cell cycle control, cell growth and differentiation,
and extracellular matrix production, as well as leukocyteUnited Kingdom
development and function (reviewed in Letterio and
Roberts, 1998). The mechanisms of TGF-b signaling and
the control of target gene expression have been charac-Summary
terized in considerable detail (reviewed in Heldin et al.,
1997; Massague and Wotton, 2000). TGF-b1 effects onTo determine the role of the pleiotropic cytokine TGF-b
in B cells, we generated mice lacking the TGF-b recep- T cells account for some of its homeostatic properties
during immune responses, as treatment of TGF-b1-defi-tor (TbR) type II selectively in this cell type through
conditional mutagenesis (Cre/loxP). The absence of cient mice with anti-CD4 antibody reduces the severity
of the mutant phenotype (Letterio et al., 1996). Also,TbRII in B cells leads to a reduced life span of conven-
tional B cells, expansion of peritoneal B-1 cells, B cell inhibition of TGF-b signaling in T cells by a transgene-
encoded dominant-negative receptor mutant leads tohyperplasia in Peyer’s patches, elevated serum immu-
noglobulin, and substantial IgG3 responses to a nor- an inflammatory phenotype similar to but less severe
than that of TGF-b1-deficient mice (Gorelik and Flavell,mally weak immunogen. This B cell hyperresponsive-
ness is associated with a virtually complete serum IgA 2000). Given that the TGF-b12/2 phenotype seems to be
lymphocyte mediated (Diebold et al., 1995) and onlydeficiency. The data reveal differential roles of TbR
in homeostasis and antigen responsiveness of B cell partial reversion is obtained by experimental inhibition
of T cell activity, the lack of TGF-b-mediated signals in Bsubpopulations and establish a critical function of the
TGF-b receptor ligand pair in the induction of IgA re- cells may contribute to the pathogenesis of a TGF-b1
deficiency.sponses in vivo.
In vitro, TGF-b1 can inhibit B cell proliferation, anti-
body secretion, and expression of surface molecules,Introduction
including antigen receptors. It also stimulates MHC
class II expression and induces the differentiation of IgA-Rigorous positive selection during development and
antigen-driven responses mediates “quality control,” secreting plasma cells (reviewed in Letterio and Roberts,
1998). TGF-b-mediated induction of IgA expression in-which ensures that B cells express functional antibody
initially, followed by antigen-specific Ig of increasing volves mobilization of transcription factor CBFa3 (AML2)
binding to the Iga germline promoter and “sterile” tran-affinity during immune responses (Rajewsky, 1996). B
cell responsiveness is controlled by accessory mole- scription of the locus, which is known to play a critical
role in immunoglobulin class switch (Lorenz and Rad-cules that link antigen receptors into inhibitory or stimu-
latory signaling pathways, depending on the nature of bruch, 1997; Shi and Stavnezer, 1998). Whether TGF-b
is essential for appropriate B cell function and/or induc-the antigen and the circumstances under which antigen
is encountered (reviewed in Healy and Goodnow, 1998; tion of IgA responses in vivo, however, remained un-
certain.Fearon and Carroll, 2000). In addition, interaction with
antigen-specific helper T cells is mandatory for the mo- To determine the B cell–specific function of the TGF-b
receptor (TbR) ligand pair in vivo, we generated a mousebilization of efficient antibody responses to protein anti-
gens and the establishment of B cell memory. line in which the gene encoding the ligand binding
chain of the TbR, TbR type II (TbRII) (Lawler et al., 1994;Secreted signaling molecules, which stimulate or in-
hibit effector functions of distinct leukocyte subsets, Takenoshita et al., 1996; Heldin et al., 1997), can be
play a central role in the direction and control of immune inactivated by cell type–specific mutagenesis using the
responses (Mosmann and Coffman, 1989; Sher et al., Cre/loxP system (Sauer and Henderson, 1988; Rajewsky
1992). The importance of inhibitory cytokines such as et al., 1996). A mouse line carrying the TbRII locus con-
TGF-b1 and IL-10 in immune homeostasis is reflected ditioned for Cre-mediated inactivation in vivo through
in the phenotype of mice unable to produce these mole- introduction of loxP sites (“floxed”; TbRIIfl) was gener-
cules. While the absence of IL-10 causes enterocolitis ated by homologous recombination in embryonic stem
(Ku¨hn et al., 1993) that is mediated by Th1 cells (David- cells. By intercrossing TbRIIfl mice with mice express-
son et al., 1996), TGF-b1-deficient mice develop a ing the Cre recombinase in the B cell lineage through
multifocal inflammatory disease (Shull et al., 1992; Kulk- knock in of Cre into the CD19 locus (Rickert et al.,
arni et al., 1993) with autoimmune manifestations includ- 1995, 1997), mice were produced that lack TbRII in
ing production of autoantibodies (Yaswen et al., 1996). B cells. This approach circumvents the problem of em-
bryonic lethality of a complete TbRII deficiency (Oshima
et al., 1996) and provides a genetic model with which* To whom correspondence should be addressed (e-mail: j.roes@
ucl.ac.uk). the B cell–specific function of TGF-b can be assessed
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directly, without perturbing TGF-b activity in other cell
types.
Results
Generation of Mice Lacking TbRII in B Cells
loxP sites were introduced into the TbRII locus by ho-
mologous recombination in mouse embryonic stem (ES)
cells to enable deletion of exon 3 by Cre-mediated re-
combination in vivo (Figure 1). The selection marker,
itself flanked by loxP sites, was removed from homolo-
gous recombinants by transient transfection with a Cre
expression vector (Gu et al., 1993). Clones carrying the
TbRII locus with exon 3 flanked by loxP sites (TbRIIfl)
were used to generate chimeric mice and to establish
a mutant mouse line through germline transmission.
Exon 3 encodes the membrane-proximal extracellular
parts of the receptor. Direct splicing of exon 2 to exon 4
creates a frameshift mutation and stop codon at position
187 of the open reading frame, resulting in termination
of translation before the transmembrane domain. Thus,
deletion of exon 3 from the TbRIIfl locus should result
Figure 1. Generation of Mice with a B Cell–Specific TbRII Deficiencyin complete TbRII inactivation.
To disrupt the TbRII gene selectively in B cells, TbRIIfl/1 (A) Modification of the TbRII locus gene in mouse ES cells. Configu-
ration of (i) the wild-type TbRII locus, (ii) the targeting vector, andmice were crossed with CD19cre mice (Rickert et al.,
(iii) the chromosomal locus after homologous recombination with1995), which induce efficient B lineage–specific deletion
the targeting vector are shown. (iv) Deletion of the neo gene by Cre-of loxP-flanked target sequences (Rickert et al., 1997).
mediated recombination in vitro results in ES cell clones carrying
Southern blot analysis of purified splenic B and T lym- the “floxed” locus (TbRIIfl) used to generate chimeric mice; (v) inacti-
phocytes from mice heterozygous for the CD19cre and vation of the locus in vivo by Cre-mediated recombination results
TbRIIfl loci shows efficient (93% 6 6%) B cell–specific in deletion of exon 3 and functional inactivation of the locus (TbRIID).
Exons (black boxes), lengths of diagnostic restriction fragments,deletion of TbRII (Figure 1C). Deletion levels increase
and location of probes (gray bars) used for Southern blotting arefurther to 98% 6 2% when both allelic chromosomes
shown. The targeting vector incorporates a neomycin resistancecarrying the TbRIIfl locus are present in the TbRIIfl/fl
gene (neo9) flanked by loxP sites (black triangles). The HSV-tk gene
CD19cre/1 (TbRII-B) genotype. No deletion is detectable in allows selection against random integration. B, BglII; X, Xho1; N,
T cells. The higher deletion levels observed in TbRII-B Nco1; Bs, Bsu361; and kb, kilobases.
mice compared to mice heterozygous for TbRIIfl could (B) Southern blot of BglII-digested DNA from wild-type (wt) ES cells,
homologous recombinant clone 58, neo deletion clone 14Flox, andindicate some degree of positive selection of B cells
clone 51D carrying the complete deletion probed with the exon 3unresponsive to TGF-b.
probe. Wild-type DNA shows the expected band at 7.0 kb. CloneBinding of TGF-b to TbRII leads to recruitment and
58 shows, in addition, a 2.6 kb band, as predicted for a homologous
activation of TbRI, which in turn binds and phosphory- recombination event. Cre-mediated recombination results in dele-
lates cytosolic signal transducers of the SMAD family, tion of the floxed neo9 gene in clone 14Flox, indicated by the band
Smad2 and Smad3 (Heldin et al., 1997). Expression of at 1.5 kb (iv). Clone 51D carries the full deletion and has lost the
probe binding site in the modified locus.Smad2 is readily detectable in purified B cells from both
(C) B cell–specific deletion of TbRII. Genomic DNA of purified spleniccontrols and TbRII-B mice (Figure 1D). While the protein
B cells (CD45R/B2201) and thymic T cells was digested with Nco1is highly phosphorylated upon stimulation of control B
and hybridized with the exon 2–specific probe. Efficiency of deletion,
cells with TGF-b1, phosphorylated Smad2 is undetect- normalized for cell purity (.90%), is indicated.
able in mutant B cells, confirming loss of TbR activity. (D) Western blot analysis to show loss of TGF-b responsiveness in
purified B cells from TbRII-B mice. Resting splenic B lymphocytes
were purified by depletion of CD431 splenocytes and stimulatedAbsence of TbRII Leads to Expansion of B-1 Cells
with 10 mg/ml of LPS for 30 min in the presence of rh-TGF-b1.and Peyer’s Patch B Cells in Gut-Associated
The membrane was probed sequentially with Smad2- or phospho-
Lymphoid Tissues Smad2-specific antibodies. Ponceau staining of the membrane after
Given the multifunctional nature of TGF-b and its transfer shows equal protein loading.
involvement in the control of fundamental processes
such as cell cycle control, induction of differentiation
programs, or inhibition of cell activity, the receptor inac- IgM and IgD expression showed the typical staining
profile of peripheral B cells, with the majority expressingtivation could have a major effect at any stage of B
cell development. The TbRII mutation, however, did not high levels of IgD on their surface. However, a consider-
able shift toward expression of high levels of IgM wasaffect B cell development in the bone marrow, as indi-
cated by normal frequencies of pre-B, immature B, and noted.
B-1 cells, the predominant B cell population in themature B cells (data not shown). Also, normal numbers
of md-positive B cells in the spleen indicated efficient B peritoneum, can be distinguished from the majority of
conventional B cells (B-2) by constitutive expression ofcell generation and establishment of the peripheral B
cell pool (Figure 2). Staining of splenic lymphocytes for high levels of IgM with low IgD and CD45R/B220 as well
B Cell–Specific TGF-b Receptor Type II Deficiency
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Figure 3. B Cell Life Span in TbRII-B Mice
BrdU incorporation by spleen cells or peritoneal cells over a 15 day
in vivo labeling period. Numbers refer to the percent of BrdU-positive
cells of all B cells (100%).
numbers were increased in the mutants by about 3-fold
in representative experiments (controls, 1.2 6 0.1 3 106;
mutants, 3.0 6 0.3 3 106 cells per Peyer’s patch), but
differences of up to 10-fold were observed (data not
shown). Staining for IgM and IgD expression reveals a
population of mhidlo cells in the mutants, which is hardly
detectable in the controls. The activated status of B cells
Figure 2. B Cell Subpopulations in TbRII-B Mice in this compartment is further reflected in the numbers of
Flow cytometric analysis of spleen, peritoneal cavity, and Peyer’s B cells engaged in germinal center reactions, as indi-
patch lymphocytes of control and TbRII-B mice.
cated by their positive staining for peanut agglutinin(A) IgM and IgD staining identifies characteristic subpopulations of
(Figure 2B). Also, increased numbers of B cells express-peripheral B cells in the organs.
ing high levels of CD45R/B220 and B7-2 were observed,(B) CD45R/B220 and PNA staining of Peyer’s patch leukocytes.
Boxes define characteristic B cell subpopulations, and the respec- and histological analysis confirmed this finding, reveal-
tive relative numbers are indicated as percent of double-positive ing a normal follicular structure with more prominent B
cells in the spleen or percent of total cells in peritoneum and Peyer’s cell areas and germinal centers in the mutants (data not
patches. The numbers for the PNA staining in (B) indicate percent
shown). Taken together, the absence of TbRII in B cellsof CD45R/B220-positive cells. At least three samples from different
manifests with pronounced effects on B cell populationsindividual mice were run separately or pooled in the case of the IgM
in the peritoneal cavity and Peyer’s patches, indicatingand IgD staining of Peyer’s patch leukocytes in (A).
a major role of the TGF-b receptor ligand pair in the
homeostasis of these B cell populations.
as expression of accessory molecules such as CD5 and
CD43 (Kantor and Herzenberg, 1993; Wells et al., 1994).
In contrast to the conventional B cells, which are regen- Absence of TbRII Affects the Turnover
of B Cell Populations In Vivoerated throughout life from proliferating precursors in
the bone marrow, B-1 cells are generated early in ontog- Peripheral B cells in mice are long lived, with half-lives
between several weeks and months (Fo¨rster and Rajew-eny and are maintained later in life through self-propaga-
tion. This cell population accounts for a substantial frac- sky, 1990). Since TGF-b is involved in B cell cycle control
(Bouchard et al., 1997), we tested, by in vivo BrdU label-tion of serum antibody that is thought to provide natural
“innate” protection against infection (Kantor and Her- ing, whether the turnover of B cells was affected by
the absence of TbRII. While we found no significantzenberg, 1993). TbRII-B mice had approximately three
times higher leukocyte counts in peritoneal lavage fluid difference in the proliferation of bone marrow B lineage
cells (data not shown), mature splenic B cells from mu-than controls (TbRII-B, 7.56 6 2.9 3 106, versus control,
2.6 6 0.3 3 106). Flow cytometric analysis showed that tant mice showed a 2-fold higher labeling index (control,
22.4% 6 2.1%; TbRII-B, 42.3% 6 4.1%) (Figure 3). Thisthe proportion of mhidlo B cells was increased from 48%
in controls to 75%, giving a 4.5-fold increase in total indicates that the TbR indeed plays a role in regulating
the stability and life span of the peripheral B cell pool,number of B cells (Figure 2). Costaining with CD43 (Wells
et al., 1994) confirmed that the cells were indeed B-1 perhaps through its capacity to induce and maintain cell
cycle arrest at G1. In contrast to conventional B cellscells (data not shown).
Peyer’s patches of the gut-associated lymphoid tis- (see above), B-1 cells in the mutants showed a reduced
BrdU labeling index of 6.3% 6 1.4% compared to con-sues (GALT) appeared macroscopically larger and more
distinct in TbRII-B mice than in controls. Total leukocyte trols (13.3% 6 3.1%) (Figure 3). This would indicate that
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effect of the TbRII mutation on IgA production. Signifi-
cantly, IgA was undetectable in the serum of 8-month-
old mutants, indicating that TbRII indeed plays a vital
role in the generation of IgA responses in vivo.
To assess whether the defect in IgA production was
due to inability to induce the generation of IgA-express-
ing plasma cell precursors or resulted from impaired
terminal differentiation and antibody secretion, we de-
termined IgA expression at the cellular level. While IgA-
expressing plasma cells were readily detectable in the
spleen (Figure 4B) and bone marrow (data not shown)
of the control mice, such cells are virtually absent in the
mutants. This also applies to Peyer’s patches, a rich
source of IgA-expressing B cells in normal mice (Butcher
et al., 1982). The loss of IgA-expressing cells in this
compartment is accompanied by a 5-fold increase in
the frequency of IgG1-expressing B cells (Figure 4C)—a
finding that is in line with the substantially increased
IgG1 levels in the serum of TbRII-B mutant mice.
Antigen-Induced B Cell Responses in TbRII-B Mice
Substantial antigen-specific responses were induced in
controls and TbRII-B mutants by immunization with T
cell–independent carbohydrate (ficoll) or T cell–depen-
dent protein carrier (chicken-g-globulin, CG) conjugates.
TbRII-B mice showed a rapid response to immunization
with the hapten (4-hydroxy-3-nitrophenyl)-acetyl-(NP)
conjugated to CG (Figure 5). NP-specific IgM and IgG3
were increased at least 3-fold in the mutants. The levels
of NP-specific IgG1, IgG2a, IgG2b, and IgE in the mu-
tants were similar to controls, indicating that the TbR
does not play a major role in the production of these
isotypes in responses to T cell–dependent hapten car-
rier conjugates. Mutants also mount an efficient memoryFigure 4. Antibody Production in TbRII-B Mice
response after secondary immunization with soluble an-(A) Total serum Ig levels in 8-week-old (circles) control mice (closed
tigen (28d10, Figure 5), which includes the characteristiccircles) and TbRII-B mutants (open circles). IgA was also measured
in 8-month-old mutants (triangles). p values (Mann-Whitney U test) affinity maturation of NP-specific IgG1, as assessed with
are , 0.004 for all isotypes except IgE, where differences between a plate binding assay (data not shown). Thus, the recruit-
control and mutants are not significant. ment of peripheral B cells into antibody responses and
(B) Flow cytometric analysis of IgA expression in spleen and Peyer’s the establishment of high-affinity B cell memory does
patches of 9- to 12-week-old animals. (Top) Intracellular staining to
not require TbRII expression in B cells. The fact thatdetect IgA-expressing plasma cells in spleen (n 5 3) and (bottom)
antigen-specific IgA remains undetectable even afterexpression of membrane-bound IgA on Peyer’s patch B cells.
(C) Expression of membrane-bound IgG1 on Peyer’s patch B cells. secondary immunization in the mutants, despite a sub-
Peyer’s patches from three 9-week-old animals were pooled. stantial response in the controls, confirms the vital role
of the TbR in the generation of IgA responses. Further-
more, immunization with the T cell–independent antigen
an extended survival time of B-1 cells accounts, at least NP-ficoll induced production of antigen-specific IgM
in part, for the increased size of the B-1 population in and IgG3, which were slightly enhanced in the mutants
TbRII-B mice. Rather than promoting the stability of the (data not shown).
population, as indicated in the case of conventional B We noted substantially increased NP-specific IgG3
cells, TbR expression thus appears to inhibit overt levels in TbRII-B mutants upon secondary immunization
expansion of peritoneal B-1 cells in normal mice. with soluble NP-CG (Figure 5, IgG3, 28d10). Since IgG3
production is not normally associated with immunologi-
cal memory, as indicated by the low response of theAntibody Production in TbRII-B Mice
Total serum Ig levels in 8-week-old animals were sub- control animals, this should reflect a primary response
to a normally weak immunogen. To test this directly, thestantially increased for most isotypes, except IgA, in
TbRII-B mutants (Figure 4). IgE production in both primary antibody response to a lower dose of NP-CG
in the absence of adjuvants was measured (Figure 6A).groups was close to the detection limit. Most pro-
nounced was the increase in IgG subclasses in the mu- Whereas NP-specific IgG3 was undetectable in the con-
trols, TbRII-B mutants showed a readily detectable re-tants, specifically for IgG1 with 16-fold higher levels
compared to controls. Contrasting the increase in most sponse, indicating that the absence of TbR leads to B
cell hyperresponsiveness.isotypes in the mutants, IgA levels were reduced by
almost an order of magnitude, indicating a differential We tested whether the absence of TbRII would lead
B Cell–Specific TGF-b Receptor Type II Deficiency
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Figure 5. Antibody Responses in TbRII-B
Mice
NP-specific serum antibody titers of TbRII-B
mice (open symbols) and controls (closed
symbols) at various time points after immuni-
zation with 100 mg NP-CG adsorbed to alum
as adjuvants. Note the increase in antigen-
specific IgM and IgG3, specifically after sec-
ondary boost with soluble antigen, and the
absence of IgA production in the mutants.
to the generation of anti-DNA antibodies, which can be The virtually complete absence of IgA in the serum of
older TbRII-B mice (Figure 4) was surprising, given thatfound in association with hyperresponsive B lympho-
cytes (Perkins et al., 1990; Sobel et al., 1991; O’Keefe only a partial block of IgA production had been reported
for mice deficient in TGF-b1 (van Ginkel et al., 1999),et al., 1996). Figures 6B and 6C show that sera from
9-week- or 8-month-old mutants indeed show increased and other factors, such as IL-2 or IL-5, have been shown
to synergize with TGF-b in IgA production (Coffman etbinding to double-stranded DNA, providing further evi-
dence for impaired control of B cell activation in the al., 1989; Sonoda et al., 1989). While maternally derived
TGF-b1 may well contribute a substantial fraction of theabsence of TbRII.
IgA levels observed in TGF-b1-deficient mice (van Ginkel
et al., 1999), such a mechanism does not explain theDiscussion
detectable levels of IgA in the serum of young TbRII-B
mice (Figure 4A). Leakiness of the TbRII-B system dueUsing conditional mutagenesis based on the Cre/loxP
system (Sauer and Henderson, 1988; Rajewsky et al., to incomplete deletion of the receptor may become ap-
parent only early in life. Positive selection in favor of1996), we generated a model to investigate the role of
the TGF-b receptor ligand pair in the control of B cell TbR-deficient B cells (Figure 1C) would lead to the com-
plete loss of serum IgA over time. The present studyfunction by a direct genetic approach, avoiding effects
of receptor deletion in other tissues that could mask establishes that signaling via the TGF-b receptor is in-
deed critical for the induction of serum IgA responsesthe phenotype or complicate data interpretation. Our
analysis reveals several distinct roles of the TGF-b re- in vivo and that other factors are not available to substi-
tute for TGF-b in this process. Thus, the TGF-b-medi-ceptor in B cells, which include the differential control
of homeostasis of B cell subpopulations, the negative ated induction of class switch recombination is a critical
early event in the development of IgA-expressingcontrol of B cell responsiveness to antigenic stimulation,
plasma cells, while IL-2 and/or IL-5 would rather stimu-and a critical function in the induction of IgA responses
late the maturation of IgA-secreting cells, as had beenin vivo.
suggested earlier (Coffman et al., 1989; Sonoda et al.,
1989).
The deficiency in IgA-expressing cells is associated
with an increase in IgG1-positive cells in the Peyer’s
patches (Figure 4) of TbRII-B mice. This is in line with
the high IgG1 serum levels in the mutants and could
result from arrest of class switch recombination at g1
during sequential class switch from m to a via g1 (Zan
et al., 1998). However, the possibility that increased lev-
els of IL-4, which is known to induce class switch to
Figure 6. B Cell Hyperresponsiveness in TbRII-B Mice IgG1 in vivo (Ku¨hn et al., 1991), may account for en-
Antibody titers in sera of 9-week-old (circles) or 8-month-old (trian- hanced IgG1 levels in the mutants cannot be excluded.
gles) controls (closed symbols) and TbRII-B mice (open symbols). Production of serum IgA depends on cognate interac-
(A) NP-specific IgG3 upon immunization with 20 mg (circles) or 10 tion between B-2 and T cells, while intestinal IgA can
mg (triangles) NP-CG in PBS. be produced in the absence of T cell help and is largely
(B) Anti-ds DNA reactivity (IgG1).
derived from B-1 cells (Snider et al., 1999; Macpherson(C) Levels of anti-ds DNA IgG1 normalized for the increased total
et al., 2000). Given this dichotomy of the IgA response,IgG1 levels in the mutants. One unit corresponds to 1 mg of a mono-
clonal IgG1 anti-NP antibody used as a standard. it will be necessary to establish whether TbRII-B mice
Immunity
448
produce intestinal IgA. Preliminary experiments indeed colitis upon oral administration of antigen (Neurath et al.,
1996; Powrie et al., 1996), highlighting the importance ofindicate the presence of IgA-producing plasma cells in
intestinal tissues (data not shown). Further studies will this cytokine in the maintenance of immune homeosta-
sis in the GALT. Given the hyperresponsiveness of Pey-be required to establish whether this IgA production
reflects TbR-independent generation of IgA-producing er’s patch B cells in TbRII-B mice, it thus appears that
the induction of TGF-b expression in this compartmentcells or whether B cells that retained a functional TbR
locus are selectively recruited into this compartment. plays a critical role in the inhibition of local B cell re-
sponses to antigens taken up from the intestinal lumen.While the deficient IgA production in TbRII-B mice
would support a possible role of TGF-b-related defects In contrast to conventional B cells (B-2), the B-1 cell
population is established early in ontogeny and main-in human IgA deficiency (IgAD), it has become clear that
a simple defect in TGF-b signaling does not explain the tained through self-renewal during adult life (Kantor and
Herzenberg, 1993). Accumulating evidence supports thelack of IgA in IgAD (Smith et al., 1994; Burrows and
Cooper, 1997). The B cell–specific TbR deficiency de- view that this population is maintained and positively
selected via antigen receptor specificity for commonscribed here may help to further define the sequence of
molecular events driving the generation of IgA-express- microbial structures and/or self-antigens (Hayakawa et
al., 1999; Lam and Rajewsky, 1999). Increased B celling cells in vivo.
B cell hyperresponsiveness in the absence of TbRII responsiveness due to the loss of TbRII may thus facili-
tate recruitment into the B-1 cell compartment and ex-becomes directly apparent in substantial levels of NP-
specific IgG3 produced by the mutants upon injection plain the expansion of the B-1 cell population in TbRII-B
mice. Enhanced proliferation does not account for theof soluble NP-CG (Figure 6). While immunization in the
presence of adjuvant also leads to increased NP-spe- increase in B-1 cell numbers because of their reduced
turnover, indicated by the in vivo BrdU incorporationcific IgM and IgG3 production, a significant effect on T
cell–dependent IgG1 and IgG2a is not detectable (Figure analysis (Figure 3). However, a defect in TGF-b-medi-
ated feedback inhibition, through its ability to induce5). This could indicate that T cell help rather than B cell
responsiveness limits the response at high doses of apoptosis in B lineage cells (Holder et al., 1992; Lomo
et al., 1995), could contribute to the increased B-1 cellantigen. The substantial increase in total serum IgG iso-
types, particularly IgG1 (Figure 4A), appears to contra- numbers in the mutants.
A fundamental function of TGF-b is the induction ofdict this finding. However, overall enhanced sensitivity
of TbR-deficient B cells should lead to stimulation of cell cycle arrest at G1 through inhibition of cyclin-depen-
dent kinase complexes required for cell cycle progres-antibody responses by normally “subimmunogenic”
natural antigens, leading to elevated levels of serum Ig. sion (Ewen et al., 1993; Koff et al., 1993; Bouchard et
al., 1997). Relaxed cell cycle control may well explainIncreased frequencies of B cells expressing an activated
phenotype in spleen and Peyer’s patches (Figure 2) are the increased turnover of conventional B cells in TbRII-B
mice (Figure 3). TbR would not only control the estab-consistent with this interpretation. In addition, expan-
sion of the B-1 cell population, which can contribute to lishment of the peripheral B cell pool, which consists
largely of noncycling long-lived cells in normal miceIgG1 responses (Taki et al., 1992), may play a part in the
increased IgG1 serum levels of TbRII mice. The efficient (Fo¨rster and Rajewsky, 1990), but also define a critical
checkpoint in antigen-mediated recruitment of B cells.antibody production observed in the mutants (Figure 5)
further shows that autocrine stimulation of B cells by By increasing the threshold that stops B cells from enter-
ing cell cycle upon antigen receptor engagement, theTGF-b, which can support Ig secretion in vitro (Snapper
et al., 1993), is not generally required for efficient Ig TGF-b receptor ligand pair could prevent premature B
cell activation through binding of low-avidity (auto) anti-isotype production in vivo.
Analysis of the Peyer’s patches of the GALT in the gens or minute amounts of antigen insufficient to recruit
substantial T cell help. Also, the relative enrichment ofmutant mice revealed increased B cell numbers and
expansion of germinal centers in the absence of inten- TbRII-negative B cells in homozygous mutants com-
pared to mice carrying one copy of the wild-type TbRIItional immunization. This shows that TGF-b plays a ma-
jor role in the control of B cell responsiveness in GALT. locus (Figure 2) could result from enhanced B cell re-
sponsiveness in the context of ligand-mediated selec-Peyer’s patches of the GALT are distinct compartments
in which specialized epithelial M cells deliver material tion of the peripheral B cell pool (Gu et al., 1991).
B cell hyperresponsiveness in mice lacking CD22, afrom the intestinal lumen, through transcytosis, into di-
rect contact with lymphocytes and macrophages (re- B cell surface molecule that interacts with antigen recep-
tors and inhibits B cell responsiveness through its asso-viewed in Neutra et al., 1996). While the ongoing expres-
sion of proinflammatory cytokines such as IL-2 and INF-g ciation with the phosphatase SHP-1, is associated with
reduced life span of peripheral B cells (Otipoby et al.,in this microenvironment reflects the activated state of
leukocytes, the GALT have also been linked with the 1996; Nitschke et al., 1997). Also, production of high-
affinity autoantibodies has been reported (O’Keefe etestablishment of tolerance to orally administered anti-
gen through activation of antigen-specific T cells pro- al., 1996) in this model. While the increase in B cell
responsiveness and reduced B cell life span are alsoducing anti-inflammatory cytokines (Gonnella et al.,
1998). Orally administered antigen leads to the induction observed in the TbRII-B mice described here, several
points distinguish both models. B cells in CD22-deficientof an antigen-specific subset of CD4 T cells (TH3) that
induces and maintains unresponsiveness to antigen in mice tend to express low levels of IgM, whereas the
absence of TbR leads to a discernible increase in surfacea TGF-b-dependent manner (Miller et al., 1992; Chen et
al., 1994). Furthermore, TGF-b has been shown to play a expression of this isotype (Figure 2). While the absence
of TbR has a substantial effect on the peritoneal B-1central role in the suppression of experimentally induced
B Cell–Specific TGF-b Receptor Type II Deficiency
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gene, itself flanked by loxP sites (floxed), was removed from homolo-cell population, relatively little (O’Keefe et al., 1996; Sato
gous recombinant ES cell clones by transient expression of the Creet al., 1996), if any (Otipoby et al., 1996; Nitschke et al.,
recombinase as described (Gu et al., 1993). ES cell clones carrying1997), changes occur in the B-1 cell population of CD22-
the desired deletion event, with exon 3 flanked by loxP sites, were
deficient mice. Thus, TbR appears to control B cell func- identified by PCR and Southern blot analysis. ES cell clones carrying
tion by mechanisms different from that of a B cell– the TbRII locus conditioned for Cre-mediated deletion (TbRIIfl) were
used to generate chimeric mice by morula aggregation. Chimerasspecific modulator of antigen-receptor signaling. While
were mated with BALB/c females, and offspring carrying ES cellthe anti-DNA reactivity detected in the serum of TbRII
chromosomes were identified by coat color. Mice were kept in mi-mice is in line with the enhanced B cell responsiveness
croisolator cages under specified pathogen free conditions. Mutants(Figure 6), the significance of these titers in the context
carrying the TbRIIfl locus were intercrossed with CD19Cre mice
of autoimmune disease remains unclear, as we have not (Rickert et al., 1995), which delete floxed target genes efficiently in
observed obvious signs of autoimmune pathogenesis B lineage cells (Rickert et al., 1997). Mice homozygous for TbRIIfl
(TbRIIfl/fl) and heterozygous for CD19Cre (CD19cre/1) delete the TbRIIin the mutants. The presence of anti-DNA reactivity in
in B lineage cells and were used as the test group. Littermates of theTbRII-B mice may well indicate a significant B cell–
following genotypes were used in control groups: TbRII1/1CD191/1,specific role of the TbR ligand pair in the prevention of
TbRIIfl/flCD191/1, and TbRII1/1CD19cre/1.autoimmune disease.
While antigen receptor–associated regulatory mole-
Southern Blot
cules such as the CD19/CD21 complex adjust B cell Genomic DNA was isolated as described (Laird et al., 1991), digested
responsiveness by “probing” the nature of the antigen with appropriate restriction enzymes, separated by agarose gel
electrophoresis, and transferred to nylon membranes (Amersham(Fearon and Carroll, 2000), TbR would mediate a higher
Pharmacia Biotech, UK). Hybridization of the membranes with radio-level of control by setting B cell responsiveness indepen-
labeled DNA probes was carried out as described (Church and Gil-dently of antigen and antigen receptors. TGF-b production
bert, 1984). Phosphor image analysis (Storm, Molecular Dynamics)by local tissues, leukocyte subsets, or B cells them-
was used to quantitate signals to assess deletion efficiency of the
selves would provide a means to adjust B cell respon- TbRII locus.
siveness to the antigenic drive of a specific anatomical
compartment and counterbalance “bystander” effects Detection of Smad2 by Western Blot
Resting splenic B lymphocytes were purified by depletion-magneticof stimulatory cytokines in a proinflammatory environ-
cell sorting using anti-CD43 magnetic beads (MACS, Miltenyi Bio-ment. This would help to maintain a stringent control
tech), and 2 3 106 cells/ml were stimulated with 10 mg/ml of LPSof B cell activation by reinforcing the requirement for
for 30 min in DMEM medium supplemented with 10% FCS, 1 mMefficient antigen receptor cross-linking and/or cellular
sodium pyruvate, 2 mM L-glutamine, 50 mg/ml gentamycin, 0.1 mM
interactions to drive B cells into clonal expansion and nonessential amino acids, 0.3% sodium bicarbonate, 25 mM HEPES,
differentiation into plasma cells or memory B cells. 50 mM 2-Mercaptoethanol, and 3 ng/ml rh-TGF-b1 (R&D Systems).
Na3VO4 (1 mM) was added to the culture medium before harvesting.Mice carrying the TbRII locus conditioned for Cre-
Western blots were done as described (Tkalcevic et al., 2000) exceptmediated deletion described here should help not only
that PVDF membrane (Hybond P, Amersham) was used. A rabbitto establish the cell type–specific functions of TGF-b in
polyclonal anti-phospho-Smad2 antibody (Upstate Biotechnology)immune homeostasis and its contribution to effective
was used to detect phosphorylated Smad2. Membranes were
host immunity but also facilitate the investigation of stripped by incubation in 0.1 M Glycin (pH 2.5) for 30 min at room
TGF-b-mediated control during embryonic development temperature, blocked, and reprobed with a monoclonal mouse anti-
Smad2 antibody (Transduction Laboratories). Antibody binding wasand differentiation. Given the association of the TGF-b
revealed by incubation with horseradish-peroxidase-conjugatedreceptor with the prevention of neoplastic transforma-
goat anti-rabbit IgG or rabbit anti-mouse IgG (Sigma Chemical) andtion (Markowitz et al., 1995), the TbRIIfl mouse should
developed by enhanced chemiluminescence followed by exposurefurther provide a valuable tool for the investigation of
to chemiluminescence film (Amersham Pharmacia Biotech).
cell type–specific mechanisms of growth control and
tumorigenesis in vivo. Cell Sorting
For DNA analysis, splenic B cells (CD45R/B2201) were isolated by
positive enrichment using magnetic bead separation, and resting BExperimental Procedures
cell populations used for in vitro stimulation were purified by deple-
tion of T cells, accessory cells, and activated B cells using anti-Generation of TbRIIfl Mice
CD43 beads (MACS, Miltenyi Biotec).The TbRII locus was isolated from a P1 mouse ES cell library (Strain
129Sv; Genome Systems, St Louis, MO) and partially subcloned and
sequenced to identify priming sites for PCR. The following primers Flow Cytometry
Fluorochrome-conjugated antibodies to the respective surface anti-(59–39) with internal restriction sites facilitating assembly of the tar-
geting vector were used to amplify and characterize segments of the gens of mouse lymphocytes were obtained from PharMingen (San
Diego, CA), anti-BrdU antibody from Beckton Dickinson, and FITC-genomic TbRII locus: ATACTCGAGCAGAGACTGGAGCAGCTGGA,
TCAGTCGACTCTGTGCATTCCTTAGGAAGTG, AGACTCGAGTGCT conjugated peanut agglutinin from Sigma Chemical. Stained cell
suspensions were analyzed with a FACScan flow cytometer (BectonTCTATCCAGAGACTGGTC, and CACGTCGACACCGTATGCATGA
AGCACCG. A 1.2 kb fragment spanning most of the second intron Dickinson, Mountain View, CA). For intracellular staining of Ig, cells
were fixed in PBS and 2% paraformaldehyde for 10 min at 408C(180 bp 39 of exon 2 to 90 bp 59 of exon 3) and a 6.5 kb fragment
spanning the adjacent region from 90 bp 59 of exon 3 to z6 kb into and washed in PBS, 0.5% BSA, and 0.01% sodium azide. After
permeabilization in PBS, 0.5% BSA, 0.01% sodium azide, and 0.5%the third intron were amplified. The fragments were assembled,
and a neomycin resistance gene flanked by two loxP sites was saponin (Sigma Chemical), cells were stained with the appropriate
antibodies in saponin containing buffer and washed twice with PBS,introduced upstream of exon 3. A further loxP site was introduced
into a Bsu361 site z1 kb 39 of exon 3. An HSV-Tk gene was included 0.5% BSA, 0.01% sodium azide, and 0.5% saponin, and once with
PBS, 0.5% BSA, and 0.01% sodium azide before analysis.at the 39 end of the targeting vector to allow enrichment of homolo-
gous recombinants by drug selection. Gene targeting in mouse em- For the analysis of B cell life span, mice were fed with 1 mg/ml
BrdU in the drinking water over a period of 15 days, after whichbryonic stem (ES) cells was essentially performed as described
previously (Roes and Rajewsky, 1993). The neomycin resistance incorporation of BrdU into B cell populations (Fo¨rster and Rajewsky,
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1990) was determined by flow cytometry. Cells were surface stained (1993). TGF beta inhibition of Cdk4 synthesis is linked to cell cycle
arrest. Cell 74, 1009–1020.with a biotinylated anti-CD45R/B220 antibody (RA3-6B2) or anti-
IgM and anti-IgD (Pharmingen, San Diego, CA), fixed in 70% ethanol, Fearon, T.F., and Carroll, M.C. (2000). Regulation of B lymphocyte
incubated for 30 min on ice, washed and resuspended in PBS, and responses to foreign and self-antigens by the CD19/CD21 complex.
fixed in 2% formaldehyde and 0.02% Tween 20 for 30 min on ice. Annu. Rev. Immunol. 18, 393–422.
Cells were washed in PBS and resuspended in 1 ml of 150 mM Fo¨rster, I., and Rajewsky, K. (1990). The bulk of the peripheral B-cell
NaCl, 5 mM MgCl2, and 10 mM HCl supplemented with 300 mg/ml pool in mice is stable and not rapidly renewed from the bone marrow.
DNase 1 (Sigma Chemical) for 10 min at room temperature. Cells Proc. Natl. Acad. Sci. USA 87, 4781–4784.
were then washed with PBS, 0.5% BSA, and 0.01% sodium azide,
Gonnella, P.A., Chen, Y., Inobe, J., Komagata, Y., Quartulli, M., andstained with FITC-conjugated anti-BrdU antibody (Becton Dickin-
Weiner, H.L. (1998). In situ immune response in gut-associatedson), and analyzed.
lymphoid tissue (GALT) following oral antigen in TCR-transgenic
mice. J. Immunol. 160, 4708–4718.
Immunization and Serology
Gorelik, L., and Flavell, R.A. (2000). Abrogation of TGFbeta signalingAnimals were immunized as described previously (Roes and Rajew-
in T cells leads to spontaneous T cell differentiation and autoimmunesky, 1993). Total serum Ig was determined using monoclonal iso-
disease. Immunity 12, 171–181.type-specific antibody pairs and standards, as recommended for
Gu, H., Tarlinton, D., Mu¨ller, W., Rajewsky, K., and Fo¨rster, I. (1991).capture and detection by the distributor (Pharmingen), except for
Most peripheral B cells in mice are ligand selected. J. Exp. Med.IgA and IgE, which were detected using isotype-specific alkaline
173, 1357–1371.phosphatase–conjugated antisera (Southern Biotechnology Associ-
ates). Antigen-specific Ig and affinity maturation of IgG1 were deter- Gu, H., Zou, Y.R., and Rajewsky, K. (1993). Independent control of
mined as described (Roes and Rajewsky, 1993), using the detection immunoglobulin switch recombination at individual switch regions
reagents above. Anti-DNA reactivity was determined by blocking evidenced through Cre-loxP-mediated gene targeting. Cell 73,
plates with methylated BSA (100 mg/ml) before coating with soni- 1155–1164.
cated salmon sperm DNA (50 mg/ml). Hayakawa, K., Asano, M., Shinton, S.A., Gui, M., Allman, D., Stewart,
C.L., Silver, J., and Hardy, R.R. (1999). Positive selection of natural
autoreactive B cells. Science 285, 113–116.Acknowledgments
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